awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34579911-0A562351-D3E3-4C74-B268-076F943D076D
Q34579911-0A562351-D3E3-4C74-B268-076F943D076D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34579911-0A562351-D3E3-4C74-B268-076F943D076D
52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B
P2860
Q34579911-0A562351-D3E3-4C74-B268-076F943D076D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34579911-0A562351-D3E3-4C74-B268-076F943D076D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
15681ebc3101decd14e4ca6d4d8cde0ccf9878bd
P2860
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.